Emergent wins $24.3 million contract for anthrax antibody development
This contract will be jointly administered through the Office of the Biomedical Advanced Research and Development Authority and the National Institute of Allergy and Infectious Diseases, a component
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.